William Mcewan

Company: Cancer Research UK

Job title: Fellow

Seminars:

Elucidating the Discovery of TRIM21 & the Development of Targeted Degraders Against it to Cure Neurodegenerative Diseases 3:00 pm

15:00: The story of the of TRIM21 as a viable therapeutic target against neurodegenerative diseases 15:30: Engineering antibodies and synthetic biologics to demonstrate the potential of targeted degradation against TRIM21 Development of small-molecule degraders aimed at TRIM21 for the treatment of neurodegenerative diseasesRead more

day: Day 2, PM